About Bausch Health Companies Inc.
Bausch Health Companies Inc. news and updates
Bausch Health partners with TerraCycle Inc.
Bausch + Lomb developed these programs in conjunction with TerraCycle because used contact lenses, eye care and lens care materials don't typically end up getting processed in standard recycling facilities.
Jan 1, 2022 | marketscreener.comBausch Health launched XIPERE in the United States on Mar 1st 22'.
[Operator Instructions] In March we were pleased that Bausch + Lomb announced their U.S. launch of XIPERE in the United States as the first therapy approved for macular edema associated with uveitis, a potentially blinding.
Jan 1, 2022 | seekingalpha.comJoseph Papa leaves Bausch Health as Chairman
Bausch Health (BHC) – Bausch Health announced that Chairman Joseph Papa has stepped down from the board and it was not due to any dispute or disagreement with the health care products maker.
Jan 1, 2022 | cnbc.comBausch Health partners with Globalgiving Foundation, Inc.
Additionally, in light of the humanitarian crisis in the region, Bausch Health is partnering with Global Giving, a non-profit organization, on an employee donation program with a corporate match to support the citizens of Ukraine.
Jan 1, 2022 | bauschhealth.comBausch Health invests into Sanoculis
Additionally, Bausch + Lomb has made an equity investment in Sanoculis as part of a Series C round of funding.
Jan 1, 2022 | biospace.comBausch Health partnered with Prevent Blindness America on Feb 1st 20'.
Moreover, in February 2020, Bausch Health collaborated with Prevent Blindness, a non-profit organization, to create awareness among people about macular degeneration through social media campaigns.
Jan 1, 2022 | coherentmarketinsights.comBausch Health hires Kiyoko Robertson as Surgical Territory Manager
Kiyoko Robertson has joined Bausch + Lomb as Surgical Territory Manager and will support the New South Wales territory focused on the Newcastle area.
Jan 1, 2022 | insightnews.com.auBausch Health launches report of survey results
Bausch + Lomb released a report of survey results from the company’s first Visionary Report, which was designed to identify new key insights into the value Americans place on their eyesight, as well as the ‘blind spots’ that may exist in the understanding and awareness of age-related macular degeneration (AMD).
Sep 13, 2022 | eyewire.newsBausch Health launches Ocuvite Adult 50+ eye vitamin with 30 micrograms of vitamin D
Bausch + Lomb announced the U.S. introduction of enhanced Ocuvite Adult 50+ eye vitamin with 30 micrograms of vitamin D, an antioxidant proven to help support healthy cell function.
Oct 7, 2022 | optiknow.caBausch Health hired John Paulson as Chairman of the board on Jun 1st 22'.
Read: In June, Bausch Health ( BHC ) announced the appointment of John Paulson as Chairman of the board to replace former Chairman Joseph Papa, who resigned with immediate effect.
Jun 24, 2022 | seekingalpha.comBausch Health acquired Sprout Pharmaceuticals for $1B on Jan 1st 15'.
In 2015, Bausch Health, then called Valeant Pharmaceuticals International, made a $1 billion deal to acquire women’s health company Sprout Pharmaceuticals for its hypoactive sexual desire disorder drug Addyi, which saw sluggish sales at launch.
Oct 26, 2018 | forbes.com